相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。TMEM9-v-ATPase Activates Wnt/β-Catenin Signaling Via APC Lysosomal Degradation for Liver Regeneration and Tumorigenesis
Youn-Sang Jung et al.
HEPATOLOGY (2021)
Liver transplantation for hepatocellular carcinoma: Management after the transplant
Elizabeth C. Verna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation
Zhentao Yang et al.
MOLECULAR BIOLOGY REPORTS (2020)
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
Huiyan Luo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria
Sunbin Ling et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
被撤回的出版物: HBx/ER alpha complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis (Retracted article. See JUN, 2023)
Pinbo Huang et al.
ONCOGENE (2020)
Target-oriented delivery of self-assembled immunosuppressant cocktails prolongs allogeneic orthotopic liver transplant survival
Haiyang Xie et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Colorectal cancer: the APC-lncRNA link
Pat J. Morin
JOURNAL OF CLINICAL INVESTIGATION (2019)
Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)
Wenhua Liang et al.
THERANOSTICS (2019)
Association between gene methylation and HBV infection in hepatocellular carcinoma: A meta-analysis
Cheng Zhang et al.
JOURNAL OF CANCER (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting
William Hankey et al.
CANCER AND METASTASIS REVIEWS (2018)
Mutational landscape of a chemically-induced mouse model of liver cancer
Frances Connor et al.
JOURNAL OF HEPATOLOGY (2018)
Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers
Jinming Cheng et al.
GENOME MEDICINE (2018)
Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany
Zhi Qu et al.
LANGENBECKS ARCHIVES OF SURGERY (2018)
Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
Sadegh Saghafinia et al.
CELL REPORTS (2018)
Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer
Lu Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
Elena Fernandez-Sevilla et al.
LIVER TRANSPLANTATION (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Gonzalo Sapisochin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer
Lu Zhang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes
Aurelie Van Tongelen et al.
CANCER LETTERS (2017)
Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis
Meng Liu et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2015)
DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma
Augusto Villanueva et al.
HEPATOLOGY (2015)
Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series
G. Sapisochin et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Preoperative tumour biopsy does not affect the oncologic course of patients with transplantable HCC
David Fuks et al.
JOURNAL OF HEPATOLOGY (2014)
Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications
Naoshi Nishida et al.
LIVER CANCER (2014)
Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma
Abdel-Rahman N. Zekri et al.
JOURNAL OF ADVANCED RESEARCH (2014)
Methylation of a Novel Panel of Tumor Suppressor Genes in Urine Moves Forward Noninvasive Diagnosis and Prognosis of Bladder Cancer: A 2-Center Prospective Study
Rodrigo Garcia-Baquero et al.
JOURNAL OF UROLOGY (2013)
Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next- generation sequencing
Dustin R. Masser et al.
EPIGENETICS & CHROMATIN (2013)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma
Naoshi Nishida et al.
HEPATOLOGY (2012)
Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis
Tae-Hee Um et al.
JOURNAL OF HEPATOLOGY (2011)
Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer
Monica Castro et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria
J. Zhou et al.
TRANSPLANTATION PROCEEDINGS (2008)
APC promoter methylation and protein expression in hepatocellular carcinoma
Antal Csepregi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma
Naoshi Nishida et al.
HEPATOLOGY (2008)
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC
R. Stigliano et al.
CANCER TREATMENT REVIEWS (2007)
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Riccardo Fodde et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
A Randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation
Jing Xu et al.
HEPATOLOGY (2007)
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
NM Kneteman et al.
LIVER TRANSPLANTATION (2004)
Wnt/β-catenin signaling pathway as novel cancer drug targets
HH Luu et al.
CURRENT CANCER DRUG TARGETS (2004)
Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma
B Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Molecular pathogenesis of human hepatocellular carcinoma
SS Thorgeirsson et al.
NATURE GENETICS (2002)